Posted by CityPolice-Admin on 2026-03-25 11:59:01 |
Share: Facebook | Twitter | Whatsapp | Linkedin Visits:
In Hyderabad, a growing wave of support has emerged from the medical community for paediatrician Dr. Sivaranjani Santosh, who is facing a legal notice from Johnson & Johnson Health Equity and Kenvue. Doctors’ associations across the region have strongly condemned the move, calling it an act of intimidation against a medical professional advocating for public health.
The controversy stems from Dr. Sivaranjani Santosh’s public statements and advocacy related to health awareness, where she reportedly raised concerns grounded in scientific evidence and medical research. In response, the legal notice issued by the companies has sparked outrage among healthcare professionals, who argue that such actions could discourage doctors from speaking openly on matters of public interest.
The Telangana Senior Resident Doctors Association has taken a firm stand, warning that if the legal notice is not withdrawn promptly, it will coordinate with other medical bodies to initiate collective action. This could include protests, formal representations to regulatory authorities, and wider campaigns to defend the rights of medical professionals.
Several doctors’ associations have emphasized that evidence-based medical opinions should not be suppressed through legal pressure. They argue that doctors have an ethical responsibility to inform the public about potential health risks and promote safe practices, even if such views conflict with corporate interests.
Medical experts have also pointed out that this incident raises broader concerns about the relationship between healthcare professionals and large corporations. They stress the importance of safeguarding the independence of doctors, ensuring that clinical opinions and public health advocacy remain free from external influence or fear of retaliation.
Support for Dr. Sivaranjani Santosh has been growing not only within Hyderabad but also from medical communities in other parts of the country. Many doctors have taken to professional forums and social platforms to express solidarity, highlighting the need to protect freedom of speech in the medical field.
At the same time, legal experts note that such disputes underline the need for clear guidelines regarding public statements made by healthcare professionals, especially when they involve commercial products or corporate entities. However, they also caution that legal mechanisms should not be misused to stifle genuine, research-backed concerns.
As the situation develops, all eyes are on whether Johnson & Johnson Health Equity and Kenvue will reconsider their stance and withdraw the notice. For now, the incident has ignited an important debate about medical ethics, corporate accountability, and the right of doctors to advocate for public health without fear.
The outcome of this case could set a significant precedent for how similar conflicts are handled in the future, making it a closely watched issue within both the healthcare and legal communities.